Your search for rituximab returned 217 results

Your search for rituximab returned 217 results

Sort Results:

Relevant Recent
Drug Monograph

RITUXAN

Rituximab 10mg/mL; soln for IV infusion after dilution; preservative-free.
Drug Monograph

RITUXAN HYCELA

Rituximab, hyaluronidase human 1400mg/23400 Units, 1600mg/26800 Units; soln for SC inj; preservative-free.
ASH 2011

RESORT Study: Rituximab Retreatment Produces Outcomes Comparable to Maintenance Rituximab Treatment in Patients with Previously Untreated Low Tumor Burden Follicular Lymphoma

A study of two different strategies for managing patients with asymptomatic low-tumor-burden (LTB) follicular lymphoma (FL) found retreatment with rituximab at disease progression is as effective in managing the disease as ongoing maintenance therapy, results of RESORT, a Phase 3 Eastern Cooperative Oncology Group (ECOG) study, reported at the 53rd American Society of Hematology Annual Meeting and Exposition.
News

Imbruvica Plus Rituximab Approved for Waldenström’s Macroglobulinemia

This expanded approval was based on results from the iNNOVATE study, a double-blind, placebo-controlled trial evaluating Imbruvica in combination with rituximab vs placebo + rituximab in 150 patients with either relapsed/refractory disease or previously untreated Waldenström's macroglobulinemia.